secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2024-08-19T23:59:59+00:00
Accession:  0001731122-24-001283
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 4.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro restates Q1 2024 financials due to IPR&D asset impairment error; files lawsuit for fraud
--------------------------------------------------------------------------------

- Concluded Q1 2024 financials contained material misstatement in IPR&D asset impairment; assets overstated, net loss understated.
- Error linked to termination of License Agreement for RENB-HV-01, which was deprioritized and terminated by licensor.
- Company will restate Q1 2024 Form 10-Q, expects to file amended report week of Aug 19, 2024.
- Filed suit against Weird Science LLC and others alleging fraudulent concealment of murder-for-hire scheme to induce 2018 merger.
- Seeks equitable relief including return of shares received in merger and damages.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001283/0001731122-24-001283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001283/e5891_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-001283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer